Ischemic Stroke Aspiration Systems Market Snapshot (2023 to 2033)

As per FMI Analysts, the global market is estimated to be valued at US$ 648.7 million in 2023. The overall market is projected to increase at a CAGR of 9.9% during the forecast period from 2023 to 2033. The global ischemic stroke aspiration systems market size is expected to reach US$ 1,672.8 million by 2033.

The market is growing rapidly, thanks to the increasing demand from hospitals and clinics. Further, the increasing prevalence of cardiovascular diseases and diabetes across the world is expected to drive market growth.

The key trend observed in the concerned market is the releases and approvals by key players to launch new products, thereby creating opportunities in the product market. This is expected to create a positive impact on the growth of the market in the coming years.

The lack of competent laboratory experts is hampering the expansion of the market. This is because as diagnostic laboratories deploy advanced ischemic stroke aspiration systems and automate processes, the expansion of diagnostic laboratories is also limited by a scarcity of skilled professionals.

The number of new graduates from clinical laboratory programs is decreasing, limiting the rapid expansion of the forum although the demand for ischemic stroke aspiration systems is rising. Also, the decreasing number of graduates is because clinical laboratory programs are being replaced by molecular biology and genetic programs. The market for ischemic stroke aspiration systems is projected to experience gradual growth during the forecast period due to increasing regional product penetration.

The Middle East and Africa are expected to be the least lucrative for the market due to the prevalent acceptance of ischemic stroke aspiration systems in the region.

Report Attributes or Data Points Details
Global Ischemic Stroke Aspiration Systems Market Valuation in 2022 US$ 595.3 million
Estimated Global Market Share in 2023 US$ 648.7 million
Forecasted Global Market Size by 2033 US$ 1,672.8 million
Projected Global Market Growth Rate from 2023 to 2033 9.9% CAGR
Historical Market Growth Rate from 2018 to 2022 8.7% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Various Factors Driving the Ischemic Stroke Aspiration Systems Market?

The global market has received a lot of traction in the industry in the last two decades. The increasing prevalence of cardiovascular diseases and diabetes across the world is expected to drive the propulsion in the market. Also, the key trend observed in the forum is the launches and approvals by key players to introduce new products, thereby creating key opportunities for market growth.

The market is growing significantly due to increasing product penetration in developing countries such as China and India. This is allowing manufacturers to generate revenue rapidly and drive growth.

Various global manufacturers in the market are looking for regional players for collaboration, partnership, and acquisition to expand their regional product footprint, which is expected to boost the sale of the product. In addition, increasing awareness about the possible symptoms of ischemic stroke resulting in improving treatment-seeking rates is fueling the usage of ischemic stroke aspiration systems.

Category By End User
Top Segment Hospitals
Market Share in Percentage 52.6%

Which Factors May Hinder the Global Ischemic Stroke Aspiration Systems Market Growth?

The overall market size is projected to be restrained by the factors such as the lack of skilled professionals and the high cost of equipment despite all of the potential growth opportunities. Moreover, the increased consumption of alcohol, smoking, and decreased physical activity that comes with a changed lifestyle can lead to an increased risk of ischemic stroke. However, the high cost of procedures may hamper the propulsion of the market.

A key obstacle that is expected to hamper market growth is the lack of competent laboratory experts. This is because as diagnostic laboratories deploy advanced ischemic stroke aspiration systems and automate processes, the expansion of diagnostic laboratories is also limited by a scarcity of skilled professionals.

The number of new graduates from clinical laboratory programs is decreasing although the demand for medical laboratory professionals is rising limiting the market growth. Moreover, the decreasing number of graduates is because clinical laboratory programs are being replaced by molecular biology and genetic programs.

Regional Market Comparison Global Market Share in Percentage
North America 34.4%
Europe 32.7%
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What is the Regional Analysis of the Ischemic Stroke Aspiration Systems Market Share?

In terms of volume, North America is predicted to grow notably over the projection period. Due to the higher number of procedures carried out there, the North America region is expected to generate significant growth in the global market.

The market opportunities in Latin America are expected to see gradual growth by the end of the forecast period due to increasing product penetration, despite steady declining growth in the past few years.

Regional Market Comparison Global Market Share in Percentage
The United States 31.8%
Germany 8.8%
Japan 4.7%

Europe's market is expected to be the second leading market because the number of ischemic stroke aspiration systems for controlling ischemic strokes has increased steadily in recent years. Further, a significantly improving healthcare infrastructure is driving the notable growth of the Asia Pacific region and is expected to make the region one of the significantly growing regions throughout the forecast period.

The forum is expected to be the least leading market in the global market in the Middle East and Africa as it is anticipated as the least adopted product in this region.

Regional Markets CAGR (2023 to 2033)
The United Kingdom 9.5%
China 13.2%
India 12.8%
Australia 8.1%

Market Competition

Some of the leading companies operating in the global ischemic stroke aspiration systems market include Medtronic, Penumbra, Inc., Insera Therapeutics, Imperative Care Inc., and others. Further, the biggies have adopted several main tactics, including increasing manufacturing capacity and developing new products.

A large portfolio of products from other medical device markets and Medtronic's strong presence in the stent retrieval market might prove beneficial to Medtronic in establishing a strong presence in the marketplace. Further, this can also be said for PTA Drug-Eluting Balloons, which Medtronic previously demonstrated in the catheter market.

Medtronic's Riptide system is approved for use with their existing Arc catheter, intracranial support catheters will typically cost less than Penumbra's aspiration catheter; therefore, the lower disposable cost is going to prove advantageous for Medtronic when competing against Penumbra's ACE system.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Report Scope

Report Attributes Details
Growth Rate CAGR of 9.9% from 2023 to 2033
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in US$ million, Volume in Kilotons, and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • The Middle East and Africa
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Australia
  • New Zealand
  • China
  • India
  • Japan
  • ASIAN
  • GCC
  • South Africa
  • North Africa
Key Companies Profiled
  • Medtronic
  • Penumbra, Inc.
  • Insera Therapeutics
  • Imperative Care Inc.
  • Others
Customization & Pricing Available Upon Request

Key Segments Profiled in the Ischemic Stroke Aspiration Systems Market

By End User :

  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Other End Users

By Region :

  • North America Market
  • Latin America Market
  • Europe Market
  • East Asia Market
  • South Asia and Pacific Market
  • The Middle East and Africa (MEA) Market

Frequently Asked Questions

What is the Projected Size of the Market by 2033?

The global market is expected to be worth US$ 2.8 billion by 2033.

What is the Growth Forecast for the Ischemic Stroke Aspiration Systems Market?

The market is forecast to register a CAGR of 9.9% from 2023 to 2033.

How India is Performing in the Ischemic Stroke Aspiration Systems Market?

Improving healthcare infrastructure in India is capturing a huge revenue in the global market.

Which is the End User Category for the Ischemic Stroke Aspiration Systems?

The hospital segment contributes a maximum share of the market.

Which is the Significantly Growing Country in the Market?

China is a significantly growing country capturing a CAGR of 13.2%.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Product Life Cycle Analysis
    3.5. Supply Chain Analysis
        3.5.1. Supply Side Participants and their Roles
            3.5.1.1. Producers
            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
            3.5.1.3. Wholesalers and Distributors
        3.5.2. Value Added and Value Created at Node in the Supply Chain
        3.5.3. List of Raw Material Suppliers
        3.5.4. List of Existing and Potential Buyer’s
    3.6. Investment Feasibility Matrix
    3.7. Value Chain Analysis
        3.7.1. Profit Margin Analysis
        3.7.2. Wholesalers and Distributors
        3.7.3. Retailers
    3.8. PESTLE and Porter’s Analysis
    3.9. Regulatory Landscape
        3.9.1. By Key Regions
        3.9.2. By Key Countries
    3.10. Regional Parent Market Outlook
    3.11. Production and Consumption Statistics
    3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
        5.3.1. Hospitals
        5.3.2. Ambulatory Surgery Centers
        5.3.3. Specialty Clinics
    5.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    6.1. Introduction
    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
    6.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
        6.3.1. North America
        6.3.2. Latin America
        6.3.3. Western Europe
        6.3.4. Eastern Europe
        6.3.5. South Asia and Pacific
        6.3.6. East Asia
        6.3.7. Middle East and Africa
    6.4. Market Attractiveness Analysis By Region
7. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    7.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    7.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        7.2.1. By Country
            7.2.1.1. USA.
            7.2.1.2. Canada
        7.2.2. By End User
    7.3. Market Attractiveness Analysis
        7.3.1. By Country
        7.3.2. By End User
    7.4. Key Takeaways
8. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        8.2.1. By Country
            8.2.1.1. Brazil
            8.2.1.2. Mexico
            8.2.1.3. Rest of Latin America
        8.2.2. By End User
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By End User
    8.4. Key Takeaways
9. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. Germany
            9.2.1.2. United Kingdom.
            9.2.1.3. France
            9.2.1.4. Spain
            9.2.1.5. Italy
            9.2.1.6. Rest of Western Europe
        9.2.2. By End User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By End User
    9.4. Key Takeaways
10. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Poland
            10.2.1.2. Russia
            10.2.1.3. Czech Republic
            10.2.1.4. Romania
            10.2.1.5. Rest of Eastern Europe
        10.2.2. By End User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By End User
    10.4. Key Takeaways
11. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. India
            11.2.1.2. Bangladesh
            11.2.1.3. Australia
            11.2.1.4. New Zealand
            11.2.1.5. Rest of South Asia and Pacific
        11.2.2. By End User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By End User
    11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. China
            12.2.1.2. Japan
            12.2.1.3. South Korea
        12.2.2. By End User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By End User
    12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. GCC Countries
            13.2.1.2. South Africa
            13.2.1.3. Israel
            13.2.1.4. Rest of MEA
        13.2.2. By End User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By End User
    13.4. Key Takeaways
14. Key Countries Market Analysis
    14.1. USA.
        14.1.1. Pricing Analysis
        14.1.2. Market Share Analysis, 2022
            14.1.2.1. By End User
    14.2. Canada
        14.2.1. Pricing Analysis
        14.2.2. Market Share Analysis, 2022
            14.2.2.1. By End User
    14.3. Brazil
        14.3.1. Pricing Analysis
        14.3.2. Market Share Analysis, 2022
            14.3.2.1. By End User
    14.4. Mexico
        14.4.1. Pricing Analysis
        14.4.2. Market Share Analysis, 2022
            14.4.2.1. By End User
    14.5. Germany
        14.5.1. Pricing Analysis
        14.5.2. Market Share Analysis, 2022
            14.5.2.1. By End User
    14.6. United Kingdom.
        14.6.1. Pricing Analysis
        14.6.2. Market Share Analysis, 2022
            14.6.2.1. By End User
    14.7. France
        14.7.1. Pricing Analysis
        14.7.2. Market Share Analysis, 2022
            14.7.2.1. By End User
    14.8. Spain
        14.8.1. Pricing Analysis
        14.8.2. Market Share Analysis, 2022
            14.8.2.1. By End User
    14.9. Italy
        14.9.1. Pricing Analysis
        14.9.2. Market Share Analysis, 2022
            14.9.2.1. By End User
    14.10. Poland
        14.10.1. Pricing Analysis
        14.10.2. Market Share Analysis, 2022
            14.10.2.1. By End User
    14.11. Russia
        14.11.1. Pricing Analysis
        14.11.2. Market Share Analysis, 2022
            14.11.2.1. By End User
    14.12. Czech Republic
        14.12.1. Pricing Analysis
        14.12.2. Market Share Analysis, 2022
            14.12.2.1. By End User
    14.13. Romania
        14.13.1. Pricing Analysis
        14.13.2. Market Share Analysis, 2022
            14.13.2.1. By End User
    14.14. India
        14.14.1. Pricing Analysis
        14.14.2. Market Share Analysis, 2022
            14.14.2.1. By End User
    14.15. Bangladesh
        14.15.1. Pricing Analysis
        14.15.2. Market Share Analysis, 2022
            14.15.2.1. By End User
    14.16. Australia
        14.16.1. Pricing Analysis
        14.16.2. Market Share Analysis, 2022
            14.16.2.1. By End User
    14.17. New Zealand
        14.17.1. Pricing Analysis
        14.17.2. Market Share Analysis, 2022
            14.17.2.1. By End User
    14.18. China
        14.18.1. Pricing Analysis
        14.18.2. Market Share Analysis, 2022
            14.18.2.1. By End User
    14.19. Japan
        14.19.1. Pricing Analysis
        14.19.2. Market Share Analysis, 2022
            14.19.2.1. By End User
    14.20. South Korea
        14.20.1. Pricing Analysis
        14.20.2. Market Share Analysis, 2022
            14.20.2.1. By End User
    14.21. GCC Countries
        14.21.1. Pricing Analysis
        14.21.2. Market Share Analysis, 2022
            14.21.2.1. By End User
    14.22. South Africa
        14.22.1. Pricing Analysis
        14.22.2. Market Share Analysis, 2022
            14.22.2.1. By End User
    14.23. Israel
        14.23.1. Pricing Analysis
        14.23.2. Market Share Analysis, 2022
            14.23.2.1. By End User
15. Market Structure Analysis
    15.1. Competition Dashboard
    15.2. Competition Benchmarking
    15.3. Market Share Analysis of Top Players
        15.3.1. By Regional
        15.3.2. By End User
16. Competition Analysis
    16.1. Competition Deep Dive
        16.1.1. Medtronic
            16.1.1.1. Overview
            16.1.1.2. Product Portfolio
            16.1.1.3. Profitability by Market Segments
            16.1.1.4. Sales Footprint
            16.1.1.5. Strategy Overview
                16.1.1.5.1. Marketing Strategy
                16.1.1.5.2. Product Strategy
                16.1.1.5.3. Channel Strategy
        16.1.2. Penumbra, Inc.
            16.1.2.1. Overview
            16.1.2.2. Product Portfolio
            16.1.2.3. Profitability by Market Segments
            16.1.2.4. Sales Footprint
            16.1.2.5. Strategy Overview
                16.1.2.5.1. Marketing Strategy
                16.1.2.5.2. Product Strategy
                16.1.2.5.3. Channel Strategy
        16.1.3. Insera Therapeutics
            16.1.3.1. Overview
            16.1.3.2. Product Portfolio
            16.1.3.3. Profitability by Market Segments
            16.1.3.4. Sales Footprint
            16.1.3.5. Strategy Overview
                16.1.3.5.1. Marketing Strategy
                16.1.3.5.2. Product Strategy
                16.1.3.5.3. Channel Strategy
        16.1.4. Imperative Care Inc.
            16.1.4.1. Overview
            16.1.4.2. Product Portfolio
            16.1.4.3. Profitability by Market Segments
            16.1.4.4. Sales Footprint
            16.1.4.5. Strategy Overview
                16.1.4.5.1. Marketing Strategy
                16.1.4.5.2. Product Strategy
                16.1.4.5.3. Channel Strategy
        16.1.5. Stryker Corporation
            16.1.5.1. Overview
            16.1.5.2. Product Portfolio
            16.1.5.3. Profitability by Market Segments
            16.1.5.4. Sales Footprint
            16.1.5.5. Strategy Overview
                16.1.5.5.1. Marketing Strategy
                16.1.5.5.2. Product Strategy
                16.1.5.5.3. Channel Strategy
        16.1.6. Terumo Corporation
            16.1.6.1. Overview
            16.1.6.2. Product Portfolio
            16.1.6.3. Profitability by Market Segments
            16.1.6.4. Sales Footprint
            16.1.6.5. Strategy Overview
                16.1.6.5.1. Marketing Strategy
                16.1.6.5.2. Product Strategy
                16.1.6.5.3. Channel Strategy
        16.1.7. MicroVention, Inc.
            16.1.7.1. Overview
            16.1.7.2. Product Portfolio
            16.1.7.3. Profitability by Market Segments
            16.1.7.4. Sales Footprint
            16.1.7.5. Strategy Overview
                16.1.7.5.1. Marketing Strategy
                16.1.7.5.2. Product Strategy
                16.1.7.5.3. Channel Strategy
        16.1.8. Phenox GmbH
            16.1.8.1. Overview
            16.1.8.2. Product Portfolio
            16.1.8.3. Profitability by Market Segments
            16.1.8.4. Sales Footprint
            16.1.8.5. Strategy Overview
                16.1.8.5.1. Marketing Strategy
                16.1.8.5.2. Product Strategy
                16.1.8.5.3. Channel Strategy
        16.1.9. Rapid Medical Ltd.
            16.1.9.1. Overview
            16.1.9.2. Product Portfolio
            16.1.9.3. Profitability by Market Segments
            16.1.9.4. Sales Footprint
            16.1.9.5. Strategy Overview
                16.1.9.5.1. Marketing Strategy
                16.1.9.5.2. Product Strategy
                16.1.9.5.3. Channel Strategy
        16.1.10. Acandis GmbH
            16.1.10.1. Overview
            16.1.10.2. Product Portfolio
            16.1.10.3. Profitability by Market Segments
            16.1.10.4. Sales Footprint
            16.1.10.5. Strategy Overview
                16.1.10.5.1. Marketing Strategy
                16.1.10.5.2. Product Strategy
                16.1.10.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology

Explore Healthcare Insights

View Reports
Future Market Insights

Ischemic Stroke Aspiration Systems Market

Schedule a Call